Sign up to attend the HFSA Annual Scientific Meeting (Sept. 30-Oct. 3)!
2017 | HFSA

MyoKardia Reports Positive Topline Results in Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) in Symptomatic, Obstructive Hypertrophic Cardiomyopathy

Practice News Annual Scientific Meeting